16 employees
ProAxsis specializes in the development of laboratory-based immunoassays and tests for the detection of protease biomarkers of disease.
2013
$63K
from 1 investors over 1 rounds
ProAxsis raised $63K on October 1, 2014
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)